Contacts utiles

– Pour les dossiers de recrutement et stage : rhcom.u1149@inserm.fr

– Pour vos commandes : commandes.u1149@inserm.fr

– Pour demander une intervention informatique : info.u1149@inserm.fr

– Pour les missions : missions.u1149@inserm.fr

– Pour des questions Hygiène et Sécurité : hs.u1149@inserm.fr

– Pour le montage et les questions relatives à un projet de Recherche : projets.u1149@inserm.fr

– Pour remonter un problème avec le site web : com.u1149@inserm.fr

– Comité éditorial du site web : Pour proposer des actualités, évènements et publications à ajouter au site web : webedition.u1149@inserm.fr

Publications du CRI

Les 100 dernières publications :

Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
Published on: 2023-11-21 Ion Agirrezabal
High incidence of immune-mediated inflammatory diseases in sepsis survivors: A nationwide exposed-nonexposed epidemiological study
Published on: 2023-11-20 Arthur Mageau
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
Published on: 2023-11-14 Rémy Nicolle
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study
Published on: 2023-11-13 Romane Guilbaud
Diagnostic standard: assessing glomerular filtration rate
Published on: 2023-11-11 Pierre Delanaye
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Published on: 2023-11-11 Qinghe Zeng
Autophagy and extracellular vesicles in the liver endothelium: friends or foes?
Published on: 2023-11-08 Louise Biquard
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors
Published on: 2023-11-07 Sabrina Sidali
Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection
Published on: 2023-11-07 Hanyu Jiang
Editorial: The fundamental biology of basophils in health and disease
Published on: 2023-11-06 Christophe Pellefigues
Editorial: Advances in mast cell physiology and mast cell-driven diseases
Published on: 2023-11-06 Ulrich Blank
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
Published on: 2023-11-06 Roberto Mateo
French Interventional Radiology Centers' Uptake of Transradial Approach and Outpatient HCC Intra-Arterial Treatments
Published on: 2023-11-06 Jules Grégory
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization
Published on: 2023-11-06 Mishal Mendiratta-Lala
Differential diagnosis of small hepatocellular nodules in cirrhosis: surrogate histological criteria of TERT promoter mutations
Published on: 2023-10-30 Aurélie Beaufrère
A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery
Published on: 2023-10-27 Blandine Gatta-Cherifi
MAIT cells altered phenotype and cytotoxicity in lupus patients are linked to renal disease severity and outcome
Published on: 2023-10-27 Elena Litvinova
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Published on: 2023-10-25 Beata Kos-Kudła
Preventive Anti-inflammatory Effects of Apocynin on Acetic Acid-Induced Colitis in Rats
Published on: 2023-10-25 Ahmed Kouki
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
Published on: 2023-10-23 Gautam Mehta
Prognostic MRI features to predict postresection survivals for very early to intermediate stage hepatocellular carcinoma
Published on: 2023-10-23 Hanyu Jiang
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Published on: 2023-10-22 Marc Hilmi
Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors
Published on: 2023-10-20 Maxime Ronot
EASL-ERN position paper on liver involvement in patients with Fontan-type circulation
Published on: 2023-10-20 Luis Téllez
Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic-Dysfunction Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella
Published on: 2023-10-17 Mazen Noureddin
Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella
Published on: 2023-10-17 Mazen Noureddin
Embracing Change: From NAFLD to MASLD under the Steatotic Liver Disease Umbrella
Published on: 2023-10-17 Mazen Noureddin
Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study
Published on: 2023-10-16 Pierre Deltenre
High-resolution and quantitative spatial analysis reveal intra-ductal phenotypic and functional diversification in pancreatic cancer
Published on: 2023-10-16 Ellis Michiels
Splanchnic vein thrombosis
Published on: 2023-10-14 A Riescher-Tuczkiewicz
Fat-containing hepatocellular carcinoma in patients with cirrhosis: proposal of a diagnostic modification regarding enhancement characteristics
Published on: 2023-10-10 Anaïs Delagnes
Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits"
Published on: 2023-10-03 Yasmina Chouik
Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology
Published on: 2023-10-02 Patrick James Gleeson
Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study
Published on: 2023-09-29 Sébastien Mulé
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during surveillance of patients with cirrhosis
Published on: 2023-09-29 Pierre Nahon
Circulating Apolipoprotein B-48 as a Biomarker of Parenteral Nutrition Dependence in Adult Patients with Short Bowel Syndrome
Published on: 2023-09-28 Salma Fourati
Rescaling creatinine makes GFR estimation equations generally applicable across populations - validation results for the Lund-Malmö equation in a French cohort of sub-Saharan ancestry
Published on: 2023-09-28 Ulf Nyman
TNFα counteracts interleukin-10 anti-inflammatory pathway through the NOX2-Lyn-SHP-1 axis in human monocytes
Published on: 2023-09-27 Marwa Ben-Khemis
Hyperphagia is prominent in adult patients with short bowel syndrome: A role for the colon?
Published on: 2023-09-26 Salma Fourati
Correlation between the presence of a cecal appendix and reduced diarrhea severity in primates: new insights into the presumed function of the appendix
Published on: 2023-09-23 Maxime K Collard
A multi-national survey of experience and attitudes towards managing catheter related blood stream infections for home parenteral nutrition
Published on: 2023-09-22 Francisca Joly
Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variation
Published on: 2023-09-20 Warren van Loggerenberg
The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study
Published on: 2023-09-19 Elton Dajti
Clinical features and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission: A retrospective multicenter study
Published on: 2023-09-17 G Kemoun
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy
Published on: 2023-09-14 Bernhard Scheiner
Obesity increases the surgical complexity and risk of recurrence after midline primary ventral hernia repair: results on 2307 patients from the French Society of hernia surgery (SFCP-CH) registry database
Published on: 2023-09-13 J Turmine
Comparison of ultrasound elastography, magnetic resonance elastography and finite element model to quantify nonlinear shear modulus
Published on: 2023-09-13 Gwenaël Pagé
MAIT lymphocytes: A new therapeutic target in liver fibrosis
Published on: 2023-09-11 Morgane Mabire
Hepatitis-B virus: replication cycle, targets, and antiviral approaches
Published on: 2023-09-11 Nour Nasser
Comparison between Lung Ultrasonography Score in the Emergency Department and Clinical Outcomes of Patients with or Suspected COVID-19: An Observational Multicentric Study
Published on: 2023-09-09 Mehdi Benchoufi
Comparison Between Lung Ultrasonography Score in the Emergency Department and Clinical Outcomes of Patients With or With Suspected COVID-19: An Observational Multicentric Study
Published on: 2023-09-09 Mehdi Benchoufi
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
Published on: 2023-09-07 T Conroy
Food additive emulsifiers and risk of cardiovascular disease in the NutriNet-Santé cohort: prospective cohort study
Published on: 2023-09-06 Laury Sellem
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease
Published on: 2023-09-04 Adel Hammoutene
Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: a case series
Published on: 2023-09-01 Franck Phan
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network
Published on: 2023-08-31 Ophélie De Rycke
Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics
Published on: 2023-08-30 Martijn P A Starmans
Quantification of Urine and Plasma Porphyrin Precursors Using LC-MS in Acute Hepatic Porphyrias: Improvement in Routine Diagnosis and in the Monitoring of Kidney Failure Patients
Published on: 2023-08-23 Antoine Poli
Endoscopic Follow-Up Between 3 and 7 Years After Sleeve Gastrectomy Reveals Antral Reactive Gastropathy but no Barrett's Esophagus
Published on: 2023-08-21 Muriel Coupaye
Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosis
Published on: 2023-08-14 Yasmina Chouik
Evaluation of iron metabolism in hospitalized COVID-19 patients
Published on: 2023-08-07 Thibaud Lefebvre
CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation
Published on: 2023-08-07 Francesco Andreata
Development and validation of a new equation based on plasma creatinine and muscle mass assessed by CT scan to estimate glomerular filtration rate: a cross-sectional study
Published on: 2023-08-02 Thomas Stehlé
Dendritic cell type 3 arises from Ly6C+ monocyte-dendritic cell progenitors
Published on: 2023-07-28 Zhaoyuan Liu
Risk factors for high-risk human papillomavirus cervical infection and clearance in patients with systemic lupus erythematosus
Published on: 2023-07-25 Tiphaine Goulenok
Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysis
Published on: 2023-07-24 Zaba Valtuille
Clinical, Radiologic, and Immunologic Features of Patients With CTLA4 Deficiency With Neurologic Involvement
Published on: 2023-07-24 Cyrille Coustal
Jejunal Feeding by Gastrojejunal Tube in Pediatric Refractory Gastroesophageal Reflux Disease
Published on: 2023-07-21 Nathan Faccioli
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
Published on: 2023-07-21 Elton Dajti
Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver
Published on: 2023-07-04 Adel Hammoutene
Non-invasive prediction of microvascular invasion in patients with hepatocellular carcinoma: is there any added value in combining imaging features and radiomics?
Published on: 2023-06-30 Marco Dioguardi Burgio
The Effect of Sex-Specific Differences on IL-10-/- Mouse Colitis Phenotype and Microbiota
Published on: 2023-06-28 Casado-Bedmar Maite
Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor-related Apoptosis-inducing Ligand in FGFR3-mutated Tumors
Published on: 2023-06-28 Clarice S Groeneveld
Activating FcγR function depends on endosomal-signaling platforms
Published on: 2023-06-26 Samira Benadda
Cholangiopathy in sickle cell disease
Published on: 2023-06-24 E Vo Quang
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST
Published on: 2023-06-22 Louis de Mestier
Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes
Published on: 2023-06-10 Brune de Dreuille
Improving clinical suspicion of acute mesenteric ischemia among patients with acute abdomen: a cross-sectional study from an intestinal stroke center
Published on: 2023-06-07 Alexandre Nuzzo
Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: Who is screened for antiphospholipid syndrome?
Published on: 2023-06-05 Clothilde Gros
Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
Published on: 2023-06-03 T Ratovomanana
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring
Published on: 2023-06-03 Brune de Dreuille

Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison
Source: Publications Published on 2023-11-21
High incidence of immune-mediated inflammatory diseases in sepsis survivors: A nationwide exposed-nonexposed epidemiological study
Source: Publications Published on 2023-11-20
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
Source: Publications Published on 2023-11-14
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study
Source: Publications Published on 2023-11-13
Diagnostic standard: assessing glomerular filtration rate
Source: Publications Published on 2023-11-11
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Source: Publications Published on 2023-11-11
Autophagy and extracellular vesicles in the liver endothelium: friends or foes?
Source: Publications Published on 2023-11-08
Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors
Source: Publications Published on 2023-11-07
Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection
Source: Publications Published on 2023-11-07
Editorial: The fundamental biology of basophils in health and disease
Source: Publications Published on 2023-11-06
Editorial: Advances in mast cell physiology and mast cell-driven diseases
Source: Publications Published on 2023-11-06
Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
Source: Publications Published on 2023-11-06
French Interventional Radiology Centers' Uptake of Transradial Approach and Outpatient HCC Intra-Arterial Treatments
Source: Publications Published on 2023-11-06
Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization
Source: Publications Published on 2023-11-06
Differential diagnosis of small hepatocellular nodules in cirrhosis: surrogate histological criteria of TERT promoter mutations
Source: Publications Published on 2023-10-30